2021 has seen a number of macular disease drug developments. Macula Matters has selected a few of the most relevant.
Read More2021 has seen a number of macular disease drug developments. Macula Matters has selected a few of the most relevant.
Read MoreResults have now been presented at medical conferences in the USA.
Read MoreMDFA has released a new series of educational videos to help Aussies better understand macular disease.
Read MoreBeovu has become the third anti-VEGF drug to be subsidised by the Pharmaceutical Benefits Scheme for the treatment of wet AMD.
Read MoreDr Liubov Robman’s MDFA funded study investigated the role of nutrition in age-related macular degeneration.
Read MoreApellis announces initial results from two phase III studies in geographic atrophy.
Read MoreThe Spring 2021 Vision Voice leads with the Health Minister Greg Hunt, seeking to allay your concerns around Medicare rebate changes.
Read MoreMDFA continues to advocate against a proposal to cut Medicare rebates for eye injections and met with the Health Minister in June 2021.
Read MoreWe’re seeking to clear up any confusion around deferring eye appointments during lockdown.
Read More